Cargando…

New insights into the role of empagliflozin on diabetic renal tubular lipid accumulation

BACKGROUND: Glucose cotransporter (SGLT) 2 suppression provides potent renal protective effect during diabetic kidney disease (DKD). This work aimed to explore how empagliflozin (EMPA, the selective and strong inhibitor of SGLT2) affected renal lipid deposition among patients undergoing type 2 diabe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Hong, Chen, Juan, Hua, Yulin, Zhang, Yuyang, Liu, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396853/ https://www.ncbi.nlm.nih.gov/pubmed/35999610 http://dx.doi.org/10.1186/s13098-022-00886-x

Ejemplares similares

Empagliflozin ameliorates symptoms of diabetes and renal tubular dysfunction in a rat model of diabetes with enlarged kidney (DEK)
por: Domon, Ayaka, et al.
Publicado: (2021)

No Cytotoxic and Inflammatory Effects of Empagliflozin and Dapagliflozin on Primary Renal Proximal Tubular Epithelial Cells under Diabetic Conditions In Vitro
por: Baer, Patrick C., et al.
Publicado: (2020)

Berberine Reduces Lipid Accumulation by Promoting Fatty Acid Oxidation in Renal Tubular Epithelial Cells of the Diabetic Kidney
por: Rong, Qingfeng, et al.
Publicado: (2022)

Lipophagy deficiency exacerbates ectopic lipid accumulation and tubular cells injury in diabetic nephropathy
por: Han, Yachun, et al.
Publicado: (2021)

Empagliflozin Administration Can Decrease the Dose of Loop Diuretics and Prevent the Exacerbation of Renal Tubular Injury in Patients With Compensated Heart Failure Complicated by Diabetes
por: Shirakabe, Akihiro, et al.
Publicado: (2020)

New Insights into the Use of Empagliflozin—A Comprehensive Review
por: Forycka, Joanna, et al.
Publicado: (2022)

Paternal High Fat Diet in Rats Leads to Renal Accumulation of Lipid and Tubular Changes in Adult Offspring
por: Chowdhury, Sabiha S., et al.
Publicado: (2016)

New insights into renal lipid dysmetabolism in diabetic kidney disease
por: Mitrofanova, Alla, et al.
Publicado: (2021)

Empagliflozin Inhibits IL-1β-Mediated Inflammatory Response in Human Proximal Tubular Cells
por: Pirklbauer, Markus, et al.
Publicado: (2021)

The dual role of empagliflozin: Cardio renal protection in T2DM patients
por: Shafiq, Aimen, et al.
Publicado: (2022)

Empagliflozin in type 1 diabetes
por: Mathieu, Chantal, et al.
Publicado: (2019)

Activation of the NLRC4 inflammasome in renal tubular epithelial cell injury in diabetic nephropathy
por: Wang, Yulin, et al.
Publicado: (2021)

Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha
por: Ndibalema, Angelamellisy Revelian, et al.
Publicado: (2020)

Role of renal tubular programed cell death in diabetic kidney disease
por: Zhou, Xiaojun, et al.
Publicado: (2022)

New insights into the suppression of inflammation and lipid accumulation by JAZF1
por: Chen, Wujun, et al.
Publicado: (2022)

The role of empagliflozin in the management of type 2 diabetes by patient profile
por: Hedrington, Maka S, et al.
Publicado: (2015)

Autophagy activation contributes to lipid accumulation in tubular epithelial cells during kidney fibrosis
por: Yan, Qi, et al.
Publicado: (2018)

Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
por: Huang, Chiang-Chi, et al.
Publicado: (2021)

Impact of empagliflozin on diabetic kidney disease
por: Koya, Daisuke
Publicado: (2017)

Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease
por: Ma, Yuting, et al.
Publicado: (2022)

Study comparing the efficacy and renal safety for patients with diabetes switching from dapagliflozin to empagliflozin
por: Yang, Ai-Yu, et al.
Publicado: (2020)

Effect of Empagliflozin in Preventing Progression of Renal Dysfunction in Diabetic Patients With Compensated Heart Failure
por: Imamura, Teruhiko
Publicado: (2021)

The role of CDX2 in renal tubular lesions during diabetic kidney disease
por: Liu, Huiming, et al.
Publicado: (2021)

Empagliflozin and Renal Sodium-Hydrogen Exchange in Healthy Subjects
por: Biancalana, Edoardo, et al.
Publicado: (2023)

Comparison of cardiovascular and renal outcomes between dapagliflozin and empagliflozin in patients with type 2 diabetes without prior cardiovascular or renal disease
por: Lim, Jayoung, et al.
Publicado: (2022)

Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus
por: Anderson, John E., et al.
Publicado: (2016)

Determining the role of SGLT2 inhibition with Empagliflozin in the development of diabetic retinopathy
por: Matthews, Jennifer, et al.
Publicado: (2022)

Role of empagliflozin in chronic lithium toxicity
por: Dyson, Vicki
Publicado: (2022)

ELABELA protects against diabetic kidney disease by activating high glucose-inhibited renal tubular autophagy
por: Zheng, Xiyin, et al.
Publicado: (2023)

Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN)
por: Yuan, Yang, et al.
Publicado: (2017)

Rap1 Ameliorates Renal Tubular Injury in Diabetic Nephropathy
por: Xiao, Li, et al.
Publicado: (2014)

Effect of Empagliflozin in Preventing Progression of Renal Dysfunction in Diabetic Patients With Compensated Heart Failure　― Reply ―
por: Shirakabe, Akihiro, et al.
Publicado: (2021)

Molecular Mechanisms Linking Empagliflozin to Renal Protection in the LLC-PK1 Model of Diabetic Nephropathy
por: Mihaljević, Vjera, et al.
Publicado: (2022)

Empagliflozin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2020)

Empagliflozin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2022)

Empagliflozin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Empagliflozin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Empagliflozin Ameliorates Progression From Prediabetes to Diabetes and Improves Hepatic Lipid Metabolism: A Systematic Review
por: Hossain, Md Fahad, et al.
Publicado: (2022)

Ferroptotic stress promotes the accumulation of pro-inflammatory proximal tubular cells in maladaptive renal repair
por: Ide, Shintaro, et al.
Publicado: (2021)

The role of discoid domain receptor 1 on renal tubular epithelial pyroptosis in diabetic nephropathy
por: Zhao, Weichen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4kc9ntj7j5vgfo2cbs2amh251f